Controlled Release Pharmaceutical Composition

Patent No. EP2554168 (titled "Controlled Release Pharmaceutical Composition") was filed by Astellas Pharma on Mar 28, 2011. The application was issued on Jan 24, 2018.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2554168

ASTELLAS PHARMA
Application Number
EP11762748A
Filing Date
Mar 28, 2011
Status
Revoked
Jul 10, 2020
Publication Date
Jan 24, 2018